Search research articles
Contact Us
Filters
Showing results (31-40 of 105) with videos related to
Page
of 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
October 9, 2009
The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size
Guozheng Liu, Shuping Dou, Minmin Liang, et al.
Current Radiopharmaceuticals
|
December 24, 2011
A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG
Dengfeng Cheng, Mary Rusckowski, Yuzhen Wang, et al.
Bioconjugate Chemistry
|
March 17, 2005
Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance
Jiang He, Guozheng Liu, Jean-Luc Vanderheyden, et al.
Bioconjugate Chemistry
|
November 18, 2004
Preparation and properties of 99mTc(CO)3+-labeled N,N-bis(2-pyridylmethyl)-4-aminobutyric acid
Guozheng Liu, Shuping Dou, Jiang He, et al.
Frontiers in Pharmacology
|
August 9, 2014
Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice
Shuping Dou, John Virostko, Mary Rusckowski, et al.
Cellular and Molecular Neurobiology
|
March 11, 2016
Saikosaponin-D Reduces H<sub>2</sub>O<sub>2</sub>-Induced PC12 Cell Apoptosis by Removing ROS and Blocking MAPK-Dependent Oxidative Damage
Xuemei Lin, Songdi Wu, Qing Wang, et al.
Nuclear Medicine and Biology
|
May 29, 2002
99mTc-N, N'-bis(aminoethyl)propanediamine hexaacetic acid (BPHA): a glomerular filtration agent similar to 99mTc-DTPA
Guozheng Liu, Chunli Zhang, Fei Liu, et al.
Molecular Pharmaceutics
|
May 29, 2010
Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF
Jiang He, Yi Wang, Shuping Dou, et al.
Frontiers in Physiology
|
November 17, 2022
Effects of mixed-cooling strategies on executive functions in simulated tennis in hot and humid conditions
Minglang Wen, Guozheng Liu, Wencan Li, et al.
Nanomedicine (London, England)
|
June 23, 2026
Targeted therapy of highly aggressive thyroid papillary carcinoma by AS1411-guided nanomaterials
Yinghou Wang, Qikun Jiang, Guozheng Liu, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 105) with videos related to
Sort By:
Page
of 11
European Journal of Cancer (Oxford, England : 1990)
|
October 9, 2009
The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size
Guozheng Liu, Shuping Dou, Minmin Liang, et al.
Current Radiopharmaceuticals
|
December 24, 2011
A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG
Dengfeng Cheng, Mary Rusckowski, Yuzhen Wang, et al.
Bioconjugate Chemistry
|
March 17, 2005
Affinity enhancement bivalent morpholino for pretargeting: initial evidence by surface plasmon resonance
Jiang He, Guozheng Liu, Jean-Luc Vanderheyden, et al.
Bioconjugate Chemistry
|
November 18, 2004
Preparation and properties of 99mTc(CO)3+-labeled N,N-bis(2-pyridylmethyl)-4-aminobutyric acid
Guozheng Liu, Shuping Dou, Jiang He, et al.
Frontiers in Pharmacology
|
August 9, 2014
Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice
Shuping Dou, John Virostko, Mary Rusckowski, et al.
Cellular and Molecular Neurobiology
|
March 11, 2016
Saikosaponin-D Reduces H<sub>2</sub>O<sub>2</sub>-Induced PC12 Cell Apoptosis by Removing ROS and Blocking MAPK-Dependent Oxidative Damage
Xuemei Lin, Songdi Wu, Qing Wang, et al.
Nuclear Medicine and Biology
|
May 29, 2002
99mTc-N, N'-bis(aminoethyl)propanediamine hexaacetic acid (BPHA): a glomerular filtration agent similar to 99mTc-DTPA
Guozheng Liu, Chunli Zhang, Fei Liu, et al.
Molecular Pharmaceutics
|
May 29, 2010
Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORF
Jiang He, Yi Wang, Shuping Dou, et al.
Frontiers in Physiology
|
November 17, 2022
Effects of mixed-cooling strategies on executive functions in simulated tennis in hot and humid conditions
Minglang Wen, Guozheng Liu, Wencan Li, et al.
Nanomedicine (London, England)
|
June 23, 2026
Targeted therapy of highly aggressive thyroid papillary carcinoma by AS1411-guided nanomaterials
Yinghou Wang, Qikun Jiang, Guozheng Liu, et al.
Page
of 11